A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data

{ 'indexed': {'date-parts': [[2024, 3, 28]], 'date-time': '2024-03-28T10:40:13Z', 'timestamp': 1711622413583}, 'reference-count': 24, 'publisher': 'Elsevier BV', 'issue': '3', 'license': [ { 'start': { 'date-parts': [[2022, 3, 1]], 'date-time': '2022-03-01T00:00:00Z', 'timestamp': 1646092800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2021, 12, 15]], 'date-time': '2021-12-15T00:00:00Z', 'timestamp': 1639526400000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.fr', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2022, 3]]}, 'DOI': '10.1016/j.eururo.2021.12.013', 'type': 'journal-article', 'created': { 'date-parts': [[2021, 12, 15]], 'date-time': '2021-12-15T22:42:54Z', 'timestamp': 1639608174000}, 'page': '285-293', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 38, 'title': 'A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of ' 'Benefit, Supported by Epidemiology and In Vitro Data', 'prefix': '10.1016', 'volume': '81', 'author': [ {'given': 'Karin', 'family': 'Welén', 'sequence': 'first', 'affiliation': []}, {'given': 'Ebba', 'family': 'Rosendal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Magnus', 'family': 'Gisslén', 'sequence': 'additional', 'affiliation': []}, {'given': 'Annasara', 'family': 'Lenman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eva', 'family': 'Freyhult', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Osvaldo', 'family': 'Fonseca-Rodríguez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniel', 'family': 'Bremell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Johan', 'family': 'Stranne', 'sequence': 'additional', 'affiliation': []}, {'given': 'Åse Östholm', 'family': 'Balkhed', 'sequence': 'additional', 'affiliation': []}, {'given': 'Katarina', 'family': 'Niward', 'sequence': 'additional', 'affiliation': []}, {'given': 'Johanna', 'family': 'Repo', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Robinsson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anna J.', 'family': 'Henningsson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Johan', 'family': 'Styrke', 'sequence': 'additional', 'affiliation': []}, {'given': 'Martin', 'family': 'Angelin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elisabeth', 'family': 'Lindquist', 'sequence': 'additional', 'affiliation': []}, {'given': 'Annika', 'family': 'Allard', 'sequence': 'additional', 'affiliation': []}, {'given': 'Miriam', 'family': 'Becker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stina', 'family': 'Rudolfsson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Robert', 'family': 'Buckland', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Camilla Thellenberg', 'family': 'Carlsson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anders', 'family': 'Bjartell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anna C.', 'family': 'Nilsson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Clas', 'family': 'Ahlm', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anne-Marie Fors', 'family': 'Connolly', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anna K.', 'family': 'Överby', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andreas', 'family': 'Josefsson', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.eururo.2021.12.013_b0005', 'doi-asserted-by': 'crossref', 'first-page': '6317', 'DOI': '10.1038/s41467-020-19741-6', 'article-title': 'Male sex identified by global COVID-19 meta-analysis as a risk factor ' 'for death and ITU admission', 'volume': '11', 'author': 'Peckham', 'year': '2020', 'journal-title': 'Nat Commun'}, { 'key': '10.1016/j.eururo.2021.12.013_b0010', 'doi-asserted-by': 'crossref', 'first-page': '430', 'DOI': '10.1038/s41586-020-2521-4', 'article-title': 'Factors associated with COVID-19-related death using OpenSAFELY', 'volume': '584', 'author': 'Williamson', 'year': '2020', 'journal-title': 'Nature'}, { 'key': '10.1016/j.eururo.2021.12.013_b0015', 'doi-asserted-by': 'crossref', 'unstructured': 'Ghazizadeh Z, Majd H, Richter M, et al. Androgen regulates SARS-CoV-2 ' 'receptor levels and is associated with severe COVID-19 symptoms in men. ' 'BioRxiv preprint. https://doi.org/10.1101/2020.05.12.091082', 'DOI': '10.1101/2020.05.12.091082'}, { 'key': '10.1016/j.eururo.2021.12.013_b0020', 'doi-asserted-by': 'crossref', 'first-page': '4068', 'DOI': '10.1038/s41467-021-24342-y', 'article-title': 'The antiandrogen enzalutamide downregulates TMPRSS2 and reduces ' 'cellular entry of SARS-CoV-2 in human lung cells', 'volume': '12', 'author': 'Leach', 'year': '2021', 'journal-title': 'Nat Commun'}, { 'key': '10.1016/j.eururo.2021.12.013_b0025', 'doi-asserted-by': 'crossref', 'first-page': '14', 'DOI': '10.1016/j.mce.2009.12.022', 'article-title': 'Androgen receptor and androgen-dependent gene expression in lung', 'volume': '317', 'author': 'Mikkonen', 'year': '2010', 'journal-title': 'Mol Cell Endocrinol'}, { 'key': '10.1016/j.eururo.2021.12.013_b0030', 'article-title': 'Sex hormones promote opposite effects on ACE and ACE2 activity, ' 'hypertrophy and cardiac contractility in spontaneously hypertensive ' 'rats', 'volume': '10', 'author': 'Dalpiaz', 'year': '2015', 'journal-title': 'PLoS One'}, { 'key': '10.1016/j.eururo.2021.12.013_b0035', 'doi-asserted-by': 'crossref', 'first-page': '1040', 'DOI': '10.1016/j.annonc.2020.04.479', 'article-title': 'Androgen-deprivation therapies for prostate cancer and risk of ' 'infection by SARS-CoV-2: a population-based study (N = 4532)', 'volume': '31', 'author': 'Montopoli', 'year': '2020', 'journal-title': 'Ann Oncol'}, { 'key': '10.1016/j.eururo.2021.12.013_b0040', 'doi-asserted-by': 'crossref', 'first-page': '1419', 'DOI': '10.1016/j.annonc.2020.06.023', 'article-title': 'Does androgen deprivation therapy protect against severe complications ' 'from COVID-19?', 'volume': '31', 'author': 'Patel', 'year': '2020', 'journal-title': 'Ann Oncol'}, { 'key': '10.1016/j.eururo.2021.12.013_b0045', 'doi-asserted-by': 'crossref', 'first-page': '680', 'DOI': '10.1016/j.jaad.2020.05.079', 'article-title': 'Androgenetic alopecia present in the majority of hospitalized COVID-19 ' 'patients: the “Gabrin sign”', 'volume': '83', 'author': 'Wambier', 'year': '2020', 'journal-title': 'J Am Acad Dermatol'}, { 'key': '10.1016/j.eururo.2021.12.013_b0050', 'doi-asserted-by': 'crossref', 'first-page': '1417', 'DOI': '10.1016/j.annonc.2020.06.015', 'article-title': 'Androgen deprivation and SARS-CoV-2 in men with prostate cancer', 'volume': '31', 'author': 'Koskinen', 'year': '2020', 'journal-title': 'Ann Oncol'}, { 'key': '10.1016/j.eururo.2021.12.013_b0055', 'doi-asserted-by': 'crossref', 'first-page': '1245', 'DOI': '10.1016/0895-4356(94)90129-5', 'article-title': 'Validation of a combined comorbidity index', 'volume': '47', 'author': 'Charlson', 'year': '1994', 'journal-title': 'J Clin Epidemiol'}, { 'key': '10.1016/j.eururo.2021.12.013_b0060', 'doi-asserted-by': 'crossref', 'first-page': '373', 'DOI': '10.1016/0021-9681(87)90171-8', 'article-title': 'A new method of classifying prognostic comorbidity in longitudinal ' 'studies: development and validation', 'volume': '40', 'author': 'Charlson', 'year': '1987', 'journal-title': 'J Chronic Dis'}, { 'key': '10.1016/j.eururo.2021.12.013_b0065', 'doi-asserted-by': 'crossref', 'first-page': '21', 'DOI': '10.2147/CLEP.S282475', 'article-title': 'Adaptation of the Charlson comorbidity index for register-based ' 'research in Sweden', 'volume': '13', 'author': 'Ludvigsson', 'year': '2021', 'journal-title': 'Clin Epidemiol'}, { 'key': '10.1016/j.eururo.2021.12.013_b0070', 'doi-asserted-by': 'crossref', 'first-page': '1057', 'DOI': '10.1007/s40262-015-0283-1', 'article-title': 'Pharmacokinetic drug interaction studies with enzalutamide', 'volume': '54', 'author': 'Gibbons', 'year': '2015', 'journal-title': 'Clin Pharmacokinet'}, { 'key': '10.1016/j.eururo.2021.12.013_b0075', 'doi-asserted-by': 'crossref', 'first-page': '693', 'DOI': '10.1056/NEJMoa2021436', 'article-title': 'Dexamethasone in hospitalized patients with Covid-19', 'volume': '384', 'author': 'RECOVERY Collaborative Group', 'year': '2021', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.eururo.2021.12.013_b0080', 'doi-asserted-by': 'crossref', 'unstructured': 'Lyon M, Li J, Cullen J, et al. 5α-Reductase inhibitors are associated ' 'with reduced risk of SARS-CoV-2 infection: a matched-pair, ' 'registry-based analysis. J Urol. In press. ' 'https://doi.org/10.1097/ju.0000000000002180.', 'DOI': '10.1097/JU.0000000000002180'}, { 'key': '10.1016/j.eururo.2021.12.013_b0085', 'article-title': 'Proxalutamide significantly accelerates viral clearance and reduces ' 'time to clinical remission in patients with mild to moderate COVID-19: ' 'results from a randomized, double-blinded, placebo-controlled trial', 'volume': '13', 'author': 'Cadegiani', 'year': '2021', 'journal-title': 'Cureus'}, { 'key': '10.1016/j.eururo.2021.12.013_b0090', 'article-title': 'Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 ' 'and TMPRSS2', 'volume': '118', 'author': 'Qiao', 'year': '2020', 'journal-title': 'Proc Natl Acad Sci U S A'}, { 'key': '10.1016/j.eururo.2021.12.013_b0095', 'doi-asserted-by': 'crossref', 'first-page': '866', 'DOI': '10.1038/s41467-021-21171-x', 'article-title': 'Distinct mechanisms for TMPRSS2 expression explain organ-specific ' 'inhibition of SARS-CoV-2 infection by enzalutamide', 'volume': '12', 'author': 'Li', 'year': '2021', 'journal-title': 'Nat Commun'}, { 'key': '10.1016/j.eururo.2021.12.013_b0100', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fmed.2021.668698', 'article-title': 'Proxalutamide reduces the rate of hospitalization for COVID-19 male ' 'outpatients: a randomized double-blinded placebo-controlled trial', 'volume': '8', 'author': 'McCoy', 'year': '2021', 'journal-title': 'Front Med'}, { 'key': '10.1016/j.eururo.2021.12.013_b0105', 'doi-asserted-by': 'crossref', 'first-page': '437', 'DOI': '10.1038/s41586-020-2355-0', 'article-title': 'Viral and host factors related to the clinical outcome of COVID-19', 'volume': '583', 'author': 'Zhang', 'year': '2020', 'journal-title': 'Nature'}, { 'key': '10.1016/j.eururo.2021.12.013_b0110', 'unstructured': 'Karimi A, Nowroozi A, Alilou S, Amini E. Effects of androgen deprivation ' 'therapy on COVID-19 in patients with prostate cancer: a systematic ' 'review and meta-analysis. Urol J. In press. ' 'https://doi.org/10.22037/uj.v18i.6691.'}, { 'key': '10.1016/j.eururo.2021.12.013_b0115', 'doi-asserted-by': 'crossref', 'first-page': '4046', 'DOI': '10.1158/1078-0432.CCR-16-2339', 'article-title': 'A phase I/Ib Study of enzalutamide alone and in combination with ' 'endocrine therapies in women with advanced breast cancer', 'volume': '23', 'author': 'Schwartzberg', 'year': '2017', 'journal-title': 'Clin Cancer Res'}, { 'key': '10.1016/j.eururo.2021.12.013_b0120', 'doi-asserted-by': 'crossref', 'first-page': '2428', 'DOI': '10.1093/cid/ciaa644', 'article-title': 'Simulation of the clinical and pathological manifestations of ' 'coronavirus disease 2019 (COVID-19) in golden Syrian hamster model: ' 'implications for disease pathogenesis and transmissibility', 'volume': '71', 'author': 'Chan', 'year': '2020', 'journal-title': 'Clin Infect Dis'}], 'container-title': 'European Urology', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0302283821022247?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0302283821022247?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 2, 26]], 'date-time': '2022-02-26T03:38:20Z', 'timestamp': 1645846700000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0302283821022247'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 3]]}, 'references-count': 24, 'journal-issue': {'issue': '3', 'published-print': {'date-parts': [[2022, 3]]}}, 'alternative-id': ['S0302283821022247'], 'URL': 'http://dx.doi.org/10.1016/j.eururo.2021.12.013', 'relation': {}, 'ISSN': ['0302-2838'], 'subject': ['Urology'], 'container-title-short': 'European Urology', 'published': {'date-parts': [[2022, 3]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No ' 'Evidence of Benefit, Supported by Epidemiology and In Vitro Data', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'European Urology', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.eururo.2021.12.013', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2021 The Authors. Published by Elsevier B.V. on behalf of European ' 'Association of Urology.', 'name': 'copyright', 'label': 'Copyright'}]}